MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Current Assets (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Current Assets came in at $91.8 million in Q4 2025, down 25.71% YoY from $123.5 million in Q4 2024, and up 168.51% on a QoQ basis from $34.2 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Current Assets (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Current Assets data on file, last reported at $91.8 million in Q4 2025.

  • Quarterly Current Assets fell 25.71% year-over-year to $91.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.8 million (down 25.71% YoY) and the FY2025 annual result came in at $91.8 million, down 25.71% from the prior year.
  • Current Assets improved to $91.8 million in Q4 2025, from $34.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $230.1 million in Q1 2021 to a low of $34.2 million in Q3 2025.
  • A 5-year average of $132.9 million and a median of $141.0 million in 2022 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2023 — Current Assets jumped 37.1% — and 2025, when it tumbled 75.42%.
  • Tracing MGTX's Current Assets over 5 years: stood at $183.2 million in 2021, then fell by 15.77% to $154.3 million in 2022, then increased by 3.42% to $159.6 million in 2023, then retreated by 22.62% to $123.5 million in 2024, then decreased by 25.71% to $91.8 million in 2025.
  • The last three Current Assets figures came in at $91.8 million (Q4 2025), $34.2 million (Q3 2025), and $47.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 218.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 218.35 Mn
Dec 31, 2025 91.76 Mn
Sep 30, 2025 34.17 Mn
Jun 30, 2025 47.08 Mn
Mar 31, 2025 79.89 Mn
Dec 31, 2024 123.52 Mn
Sep 30, 2024 139.05 Mn
Jun 30, 2024 110.77 Mn
Mar 31, 2024 149.30 Mn
Dec 31, 2023 159.62 Mn
Sep 30, 2023 103.53 Mn
Jun 30, 2023 143.14 Mn
Mar 31, 2023 121.48 Mn
Dec 31, 2022 154.34 Mn
Sep 30, 2022 155.04 Mn
Jun 30, 2022 104.41 Mn
Mar 31, 2022 142.93 Mn
Dec 31, 2021 183.24 Mn
Sep 30, 2021 176.93 Mn
Jun 30, 2021 207.04 Mn